Lesson Description
The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) hosted a virtual scientific public workshop on February 25, 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop was to identify and discuss the current state of the science, development, and regulation for cellular therapies and tissue-based products.
In this session:
Welcome and Opening Remarks from FDA:
- Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research (CBER), FDA
- Nicole Verdun, MD, Super Office Director, Office of Therapeutic Products (OTP), CBER, FDA
Keynote Address: “Cell and Tissue Product Development: Past and Future Decade”
- Sally Temple, PhD, Scientific Director, The Neural Stem Cell Institute